{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:27:18Z","timestamp":1792175238218,"version":"4.4.0"},"reference-count":173,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>Globally, millions of persons have contracted the coronavirus disease 2019 (COVID-19) over the past several months, resulting in significant mortality. Health care systems are negatively impacted including the care of individuals with cancers and other chronic diseases such as chronic active hepatitis, cirrhosis and hepatocellular carcinoma. There are various probable pathogenic mechanisms that have been presented to account for liver injury in COVID-19 patients such as hepatotoxicity cause by therapeutic drugs, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection of the bile duct cells and hepatocytes, hypoxia and systemic inflammatory response. Liver biochemistry tests such as aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyl transferase (GGT) and alkaline phosphatase (ALP) are deranged in COVID-19 patients with liver injury. Hepatocellular damage results in the elevation of serum AST and ALT levels in early onset disease while a cholestatic pattern that develops as the disease progress causes higher levels of ALP, GGT, direct and total bilirubin. These liver biochemistry tests are prognostic markers of disease severity and should be carefully monitored in COVID-19 patients. We conducted a systematic review of abnormal liver biochemistry tests in COVID-19 and the possible pathogenesis involved. Significant findings regarding the severity, hepatocellular pattern, incidence and related clinical outcomes in COVID-19 patients are highlighted.<\/jats:p>","DOI":"10.3390\/diseases9030050","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T12:03:27Z","timestamp":1625141007000},"page":"50","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Abnormal Liver Biochemistry Tests and Acute Liver Injury in COVID-19 Patients: Current Evidence and Potential Pathogenesis"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8018-7722","authenticated-orcid":false,"given":"Donovan A.","family":"McGrowder","sequence":"first","affiliation":[{"name":"Department of Pathology, Faculty of Medical Sciences, The University of the West Indies, Kingston 7, Jamaica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Physical Education, Faculty of Education, The Mico University College, 1A Marescaux Road, Kingston 5, Jamaica"},{"name":"Department of Biotechnology, Faculty of Science and Technology, The University of the West Indies, Kingston 7, Jamaica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melisa","family":"Anderson Cross","sequence":"additional","affiliation":[{"name":"School of Allied Health and Wellness, College of Health Sciences, University of Technology, Kingston 7, Jamaica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9712-0214","authenticated-orcid":false,"given":"Lennox","family":"Anderson-Jackson","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medical Sciences, The University of the West Indies, Kingston 7, Jamaica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Bryan","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, Faculty of Medical Sciences, The University of the West Indies, Kingston 7, Jamaica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lowell","family":"Dilworth","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medical Sciences, The University of the West Indies, Kingston 7, Jamaica"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"key":"ref_1","first-page":"e7423","article-title":"Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): An update","volume":"12","author":"Pal","year":"2020","journal-title":"Cureus"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/s41418-020-0530-3","article-title":"COVID-19 infection: The perspectives on immune responses","volume":"27","author":"Shi","year":"2020","journal-title":"Cell Death Differ."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1172\/JCI137647","article-title":"SARS-CoV-2: A storm is raging","volume":"130","author":"Pedersen","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","volume":"27","author":"Netea","year":"2020","journal-title":"Cell Host Microbe"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Cappanera, S., Palumbo, M., Kwan, S.H., Priante, G., Martella, L.A., Saraca, L.M., Sicari, F., Vernelli, C., Di Giuli, C., and Andreani, P. (2021). When does the cytokine storm begin in COVID-19 patients? A quick score to recognize it. J. Clin. Med., 10.","DOI":"10.3390\/jcm10020297"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"110195","DOI":"10.1016\/j.biopha.2020.110195","article-title":"New understanding of the damage of SARS-CoV-2 infection outside the respiratory system","volume":"127","author":"Zhang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10735-020-09915-3","article-title":"COVID-19 and multi-organ failure: A narrative review on potential mechanisms","volume":"51","author":"Mokhtari","year":"2020","journal-title":"J. Mol. Histol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Kukla, M., Skonieczna-\u017bydecka, K., and Kotfis, K. (2020). COVID-19, MERS and SARS with concomitant liver injury-systematic review of the existing literature. J. Clin. Med., 9.","DOI":"10.3390\/jcm9051420"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jhep.2020.04.006","article-title":"COVID-19: Abnormal liver function tests","volume":"73","author":"Cai","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/liv.14435","article-title":"Liver injury during highly pathogenic human coronavirus infections","volume":"40","author":"Xu","year":"2020","journal-title":"Liver Int."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Chai, X., Hu, L., Zhang, Y., Han, W., Lu, Z., Ke, A., Zhou, J., Shi, G., Fang, N., and Fan, J. (2020). Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. BioRxiv.","DOI":"10.1101\/2020.02.03.931766"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bbapap.2004.10.010","article-title":"Membrane-associated zinc peptidase families: Comparing ACE and ACE2","volume":"1751","author":"Guy","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Fagerberg","year":"2015","journal-title":"Science"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.cgh.2020.04.040","article-title":"ACE2 Expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection","volume":"18","author":"Liu","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1128\/JVI.02062-10","article-title":"A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry","volume":"85","author":"Shulla","year":"2011","journal-title":"J. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.aohep.2020.08.062","article-title":"SARS-CoV-2 another kind of liver aggressor, how does it do that?","volume":"19","year":"2020","journal-title":"Ann. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s13238-020-00718-6","article-title":"Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids","volume":"11","author":"Zhao","year":"2020","journal-title":"Protein Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/hep4.1576","article-title":"\u03b3-Glutamyltransferase elevations are frequent in patients with COVID-19: A clinical epidemiologic study","volume":"4","author":"Shao","year":"2020","journal-title":"Hepatol. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/s41374-020-0431-6","article-title":"Retrospective analysis of laboratory testing in 54 patients with severe- or critical-type 2019 novel coronavirus pneumonia","volume":"100","author":"Li","year":"2020","journal-title":"Lab. Investig."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/426870","article-title":"Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus","volume":"191","author":"Farcas","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/hep.20111","article-title":"SARS-associated viral hepatitis caused by a novel coronavirus: Report of three cases","volume":"39","author":"Chau","year":"2004","journal-title":"Hepatology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s00204-020-02734-1","article-title":"COVID-19 and drug-induced liver injury: A problem of plenty or a petty point?","volume":"94","author":"Boeckmans","year":"2020","journal-title":"Arch. Toxicol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41575-021-00426-4","article-title":"COVID-19 and liver disease: Mechanistic and clinical perspectives","volume":"10","author":"Marjot","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/apt.15916","article-title":"Systematic review with meta-analysis: Liver manifestations and outcomes in COVID-19","volume":"52","author":"Kulkarni","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s40264-020-00966-9","article-title":"Lopinavir-Ritonavir in the treatment of COVID-19: A dynamic systematic benefit-risk assessment","volume":"43","author":"Osborne","year":"2020","journal-title":"Drug Saf."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.cgh.2020.04.002","article-title":"Clinical features of COVID-19-related liver functional abnormality","volume":"18","author":"Fan","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.medj.2020.04.001","article-title":"Efficacy and safety of lopinavir\/ritonavir or arbidol in adult patients with mild\/moderate COVID-19: An exploratory randomized controlled trial","volume":"1","author":"Li","year":"2020","journal-title":"Med"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1074\/jbc.RA120.013679","article-title":"Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency","volume":"295","author":"Gordon","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_34","unstructured":"U.S. Food and Drug Administration (2021, April 30). Remdesivir EUA Letter of Authorization, Available online: www.fda.gov\/media\/137564\/download."},{"key":"ref_35","first-page":"926","article-title":"Remdesivir for the treatment of severe COVID-19: A community hospital\u2019s experience","volume":"120","author":"Lee","year":"2020","journal-title":"J. Am. Osteopath. Assoc."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19\u2014Final Report","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/hep.31487","article-title":"Abnormal liver tests in COVID-19: A retrospective observational cohort study of 1827 patients in a major U.S. hospital network","volume":"72","author":"Hundt","year":"2020","journal-title":"Hepatology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1056\/NEJMoa2015301","article-title":"Remdesivir for 5 or 10 days in patients with severe Covid-19","volume":"383","author":"Goldman","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/phar.2464","article-title":"Acetylcysteine for the treatment of suspected remdesivir-Associated acute liver failure in COVID-19: A case series","volume":"40","author":"Carothers","year":"2020","journal-title":"Pharmacotherapy"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe Covid-19","volume":"382","author":"Grein","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: A randomized, double-blind, placebo-controlled, multi-centre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"van Laar, S.A., de Boer, M.G.J., Gombert-Handoko, K.B., Guchelaar, H.J., Zwaveling, J., and LUMC-Covid-19 Research Group (2021). Liver and kidney function in patients with Covid-19 treated with remdesivir. Br. J. Clin. Pharmacol.","DOI":"10.22541\/au.161061771.19118674\/v1"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"107672","DOI":"10.1016\/j.pharmthera.2020.107672","article-title":"Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19","volume":"216","author":"Lei","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: Implications for rheumatology","volume":"16","author":"Schrezenmeier","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/14787210.2020.1799785","article-title":"Hydroxychloroquine in the COVID-19 pandemic era: In pursuit of a rational use for prophylaxis of SARS-CoV-2 infection","volume":"19","author":"Infante","year":"2021","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/cid\/ciaa237","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","volume":"71","author":"Yao","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/jac\/dkaa114","article-title":"COVID-19: A recommendation to examine the effect of hydroxychloroquine in preventing infection and progression","volume":"75","author":"Zhou","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1056\/NEJMoa2012410","article-title":"Observational study of hydroxychloroquine in hospitalized patients with Covid-19","volume":"382","author":"Geleris","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1001\/jama.2020.8630","article-title":"Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York state","volume":"323","author":"Rosenberg","year":"2020","journal-title":"JAMA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"287","DOI":"10.7326\/M20-2496","article-title":"Hydroxychloroquine or chloroquine for treatment or prophylaxis of COVID-19: A living systematic review","volume":"173","author":"Hernandez","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e208857","DOI":"10.1001\/jamanetworkopen.2020.8857","article-title":"Effect of high vs. low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection","volume":"3","author":"Borba","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gut.35.4.569","article-title":"Fulminant hepatic failure secondary to hydroxychloroquine","volume":"35","author":"Makin","year":"1994","journal-title":"Gut"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"S1286","DOI":"10.14309\/01.ajg.0000598756.33512.43","article-title":"Hydroxychloroquine-induced acute liver injury","volume":"114","author":"Cheema","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci. Trends"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/phar.2467","article-title":"Hydroxychloroquine in hospitalized patients with COVID-19: Real-world experience assessing mortality","volume":"40","author":"Annie","year":"2020","journal-title":"Pharmacotherapy"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-3-540-73259-4_7","article-title":"Humanized antihuman IL-6 receptor antibody, tocilizumab","volume":"181","author":"Nishimoto","year":"2008","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1080\/21645515.2017.1316909","article-title":"Tocilizumab (Actemra)","volume":"13","author":"Sheppard","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"107018","DOI":"10.1016\/j.intimp.2020.107018","article-title":"Tocilizumab for treatment patients with COVID-19: Recommended medication for novel disease","volume":"89","author":"Samaee","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_60","first-page":"21","article-title":"Nomogram for prediction of fatal outcome in patients with severe COVID-19: A multicenter study","volume":"8","author":"Yang","year":"2021","journal-title":"Mil. Med. Res."},{"key":"ref_61","first-page":"S7","article-title":"The effect of tocilizumab on inflammatory markers in survivors and non-survivors of severe COVID-19","volume":"30","author":"Amin","year":"2021","journal-title":"J. Coll. Physicians Surg. Pak."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejim.2020.05.009","article-title":"Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia","volume":"76","author":"Capra","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejim.2020.05.021","article-title":"Efficacy and safety of tocilizumab in severe COVID-19 patients: A single-centre retrospective cohort study","volume":"76","author":"Campochiaro","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/jmv.26429","article-title":"Late onset infectious complications and safety of tocilizumab in the management of COVID-19","volume":"93","author":"Pettit","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejim.2020.05.011","article-title":"Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy","volume":"76","author":"Morena","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1111\/liv.14516","article-title":"First case of drug-induced liver injury associated with the use of tocilizumab in a patient with COVID-19","volume":"40","year":"2020","journal-title":"Liver Int."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/jmv.26016","article-title":"Use of subcutaneous tocilizumab in patients with COVID-19 pneumonia","volume":"93","author":"Mazzitelli","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1756284820959183","DOI":"10.1177\/1756284820959183","article-title":"Tocilizumab and liver injury in patients with COVID-19","volume":"13","author":"Serviddio","year":"2020","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/bcp.14459","article-title":"Serious adverse events with tocilizumab: Pharmacovigilance as an aid to prioritize monitoring in COVID-19","volume":"87","author":"Gatti","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1001\/jama.2015.13896","article-title":"Early administration of azithromycin and prevention of severe lower respiratory tract illnesses in preschool children with a history of such illnesses: A randomized clinical trial","volume":"314","author":"Bacharier","year":"2015","journal-title":"JAMA"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4172\/1948-5964.1000173","article-title":"Azithromycin inhibits the replication of Zika virus","volume":"10","author":"Bosseboeuf","year":"2018","journal-title":"J. Antivir. Antiretrovir."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Sandeep, S., and McGregor, K. (2020). Energetics based modeling of hydroxychloroquine and azithromycin binding to the SARS-CoV-2 spike (S) protein-ACE2 complex. ChemRxiv.","DOI":"10.26434\/chemrxiv.12015792"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial","volume":"56","author":"Gautret","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1389557521666210401093948","article-title":"Effectiveness of azithromycin as add-on therapy in COVID-19 management","volume":"21","author":"Wahab","year":"2021","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s41591-020-0888-2","article-title":"The QT interval prolongation in patients with COVID-19 treated with hydroxychloroquine and azithromycin","volume":"26","author":"Chorin","year":"2020","journal-title":"Nat. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ipej.2020.10.002","article-title":"Hydroxychloroquine and QTc prolongation in patients with COVID-19: A systematic review and meta-analysis","volume":"21","author":"Agstam","year":"2021","journal-title":"Indian Pacing Electrophysiol. J."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/bcp.14482","article-title":"Clinical outcomes and adverse events in patients hospitalized with COVID-19, treated with off-label hydroxychloroquine and azithromycin","volume":"87","author":"Kelly","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s40264-020-00953-0","article-title":"Does Ibuprofen Worsen COVID-19?","volume":"43","author":"Moore","year":"2020","journal-title":"Drug Saf."},{"key":"ref_79","first-page":"806","article-title":"What the dental practitioner needs to know about pharmaco-therapeutic modalities of COVID-19 treatment: A review","volume":"16","author":"Elsayed","year":"2020","journal-title":"J. Dent. Sci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"110982","DOI":"10.1016\/j.biopha.2020.110982","article-title":"Early use of non-steroidal anti-inflammatory drugs in COVID-19 might reverse pathogenesis, prevent complications and improve clinical outcomes","volume":"133","author":"Kelleni","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s40121-020-00363-w","article-title":"Ibuprofen and NSAID Use in COVID-19 Infected patients is not associated with worse outcomes: A prospective cohort study","volume":"10","author":"Alqahtani","year":"2021","journal-title":"Infect. Dis. Ther."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.phrs.2017.06.005","article-title":"The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases","volume":"125","author":"Li","year":"2017","journal-title":"Pharmacol. Res."},{"key":"ref_83","first-page":"131","article-title":"Acetaminophen-Induced Hepatotoxicity: A Comprehensive Update","volume":"4","author":"Yoon","year":"2016","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_84","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases (2021, April 30). Acetaminophen, LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548162\/."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.dld.2020.09.010","article-title":"COVID 19 and liver: An A-Z literature review","volume":"53","author":"Metawea","year":"2021","journal-title":"Dig. Liver Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1111\/liv.14565","article-title":"Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19","volume":"40","author":"Piano","year":"2020","journal-title":"Liver Int."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/hep.31480","article-title":"Abnormal Liver Function Tests in Patients With COVID-19: Relevance and Potential Pathogenesis","volume":"72","author":"Bertolini","year":"2020","journal-title":"Hepatology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s42399-020-00363-4","article-title":"Comorbidity and its impact on patients with COVID-19","volume":"25","author":"Sanyaolu","year":"2020","journal-title":"SN Compr. Clin. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5694\/mja2.50674","article-title":"COVID-19 acute respiratory distress syndrome (ARDS): Clinical features and differences from typical pre-COVID-19 ARDS","volume":"213","author":"Gibson","year":"2020","journal-title":"Med. J. Aust."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.12998\/wjcc.v8.i19.4303","article-title":"Liver injury in COVID-19: A minireview","volume":"8","author":"Zhao","year":"2020","journal-title":"World J. Clin. Cases"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejim.2020.05.035","article-title":"Hepatic consequences of COVID-19 infection. Lapping or biting","volume":"77","author":"Portincasa","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"ref_92","first-page":"97","article-title":"Novel coronavirus pneumonia-related liver injury: Etiological analysis and treatment strategy","volume":"28","author":"Hu","year":"2020","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"ref_93","first-page":"100","article-title":"Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus-infected pneumonia","volume":"28","author":"Guan","year":"2020","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1503\/cmaj.1040752","article-title":"Liver enzyme alteration: A guide for clinicians","volume":"172","author":"Giannini","year":"2005","journal-title":"Can. Med. Assoc. J."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4081\/cp.2020.1271","article-title":"COVID-19: Hemoglobin, iron, and hypoxia beyond inflammation. A narrative review","volume":"10","author":"Cavezzi","year":"2020","journal-title":"Clin. Pract."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ijid.2020.05.110","article-title":"Iron: Innocent bystander or vicious culprit in COVID-19 pathogenesis?","volume":"97","author":"Edeas","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jceh.2020.03.001","article-title":"Gastrointestinal and liver manifestations of COVID-19","volume":"10","author":"Agarwal","year":"2020","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_98","first-page":"142","article-title":"Gastrointestinal and hepatic manifestations of COVID-19: Evolving recognition and need for increased understanding in vulnerable populations","volume":"113","author":"Garland","year":"2021","journal-title":"J. Natl. Med. Assoc."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"584342","DOI":"10.3389\/fmed.2020.584342","article-title":"Multicenter analysis of liver injury patterns and mortality in COVID-19","volume":"7","author":"Chu","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"key":"ref_100","first-page":"7855","article-title":"Severe COVID-19 patients with liver injury: A seven-case series","volume":"24","author":"Li","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/hep.31446","article-title":"Clinical features of patients infected with coronavirus disease 2019 with elevated liver biochemistries: A multicenter, retrospective study","volume":"73","author":"Fu","year":"2021","journal-title":"Hepatology"},{"key":"ref_102","first-page":"107","article-title":"Molecular and cellular mechanisms of liver dysfunction in COVID-19","volume":"30","author":"Huang","year":"2020","journal-title":"Discov. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"106054","DOI":"10.1016\/j.ijantimicag.2020.106054","article-title":"Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): A global pandemic and treatment strategies","volume":"56","author":"Sharma","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3389\/fimmu.2020.01441","article-title":"Immune response, inflammation, and the clinical spectrum of COVID-19","volume":"11","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3389\/fimmu.2020.01021","article-title":"Novel Coronavirus-induced NLRP3 inflammasome activation: A potential drug target in the treatment of COVID-19","volume":"11","author":"Shah","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cytogfr.2020.06.001","article-title":"SARS-CoV-2 infection: The role of cytokines in COVID-19 disease","volume":"54","author":"Ruiz","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"607647","DOI":"10.3389\/fped.2020.607647","article-title":"Biomarkers in COVID-19: An up-to-date review","volume":"8","author":"Samprathi","year":"2021","journal-title":"Front. Pediatrics"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3389\/fimmu.2020.01708","article-title":"Cytokine storm in COVID-19: The current evidence and treatment strategies","volume":"11","author":"Tang","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1007\/s10875-020-00824-4","article-title":"Immunologic features in coronavirus disease 2019: Functional exhaustion of T cells and cytokine storm","volume":"40","author":"Mahmoudi","year":"2020","journal-title":"J. Clin. Immunol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1136\/gutjnl-2020-321913","article-title":"Risk factors in patients with COVID-19 developing severe liver injury during hospitalization","volume":"70","author":"Zhan","year":"2021","journal-title":"Gut"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/hep.31404","article-title":"Acute liver injury in COVID-19: Prevalence and association with clinical outcomes in a large U.S. cohort","volume":"72","author":"Phipps","year":"2020","journal-title":"Hepatology"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2020.06.017","article-title":"Cytokine storms: Understanding COVID-19","volume":"53","author":"Mangalmurti","year":"2020","journal-title":"Immunity"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Wi\u015bniewska, H., Skonieczna-\u017bydecka, K., Parczewski, M., Ni\u015bcigorska-Olsen, J., Karpi\u0144ska, E., Hornung, M., Jurczyk, K., Witak-J\u0119dra, M., Laurans, \u0141., and Maciejewska, K. (2021). Hepatotropic properties of SARS-CoV-2-preliminary results of cross-sectional observational study from the first wave COVID-19 pandemic. J. Clin. Med., 10.","DOI":"10.3390\/jcm10040672"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1097\/MEG.0000000000001806","article-title":"Case series and review of liver dysfunction in COVID-19 patients","volume":"32","author":"Kudaravalli","year":"2020","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.dld.2020.08.004","article-title":"Systemic inflammation as fuel for acute liver injury in COVID-19","volume":"53","author":"Effenberger","year":"2021","journal-title":"Dig. Liver Dis."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/2050640620924157","article-title":"Liver injury in COVID-19: The current evidence","volume":"8","author":"Alqahtani","year":"2020","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/hep4.1631","article-title":"Liver injury in hospitalized patients with COVID-19 correlates with hyper inflammatory response and elevated IL-6","volume":"5","author":"Da","year":"2020","journal-title":"Hepatol. Commun."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s12072-020-10075-5","article-title":"Clinical characteristics and risk factors of liver injury in COVID-19: A retrospective cohort study from Wuhan, China","volume":"14","author":"Wang","year":"2020","journal-title":"Hepatol. Int."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1007\/s11427-020-1733-4","article-title":"Decreased serum albumin level indicates poor prognosis of COVID-19 patients: Hepatic injury analysis from 2,623 hospitalized cases","volume":"63","author":"Huang","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/liv.14465","article-title":"Coronavirus disease 2019 and prevalence of chronic liver disease: A meta-analysis","volume":"40","author":"Mantovani","year":"2020","journal-title":"Liver Int."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Oyelade, T., Alqahtani, J., and Canciani, G. (2020). Prognosis of COVID-19 in patients with liver and kidney diseases: An early systematic review and meta-analysis. Trop. Med. Infect. Dis., 5.","DOI":"10.20944\/preprints202004.0464.v1"},{"key":"ref_122","first-page":"433","article-title":"Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: A multi-centre cohort study","volume":"70","author":"Qi","year":"2021","journal-title":"Gut"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1007\/s12250-020-00276-5","article-title":"Clinical characteristics of hospitalized patients with SARS-CoV-2 and hepatitis B virus co-infection","volume":"35","author":"Chen","year":"2020","journal-title":"Virol. Sin."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/MEG.0000000000001742","article-title":"Chronic liver disease is not associated with severity or mortality in Coronavirus disease 2019 (COVID-19): A pooled analysis","volume":"33","author":"Lippi","year":"2021","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S2468-1253(20)30057-1","article-title":"Liver injury in COVID-19: Management and challenges","volume":"5","author":"Zhang","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.3748\/wjg.v20.i18.5442","article-title":"Cirrhosis and its complications: Evidence based treatment","volume":"20","author":"Nusrat","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"100169","DOI":"10.1016\/j.jhepr.2020.100169","article-title":"Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic","volume":"2","author":"Boettler","year":"2020","journal-title":"JHEP Rep."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/cld.974","article-title":"Chronic liver disease and COVID-19: Alcohol Use disorder\/alcohol-associated liver disease, nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis, autoimmune liver disease, and compensated cirrhosis","volume":"15","author":"Kushner","year":"2020","journal-title":"Clin. Liver Dis."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrgastro.2016.168","article-title":"Liver-guardian, modifier and target of sepsis","volume":"14","author":"Strnad","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Galiero, R., Pafundi, P.C., Simeon, V., Rinaldi, L., Perrella, A., Vetrano, E., Caturano, A., Alfano, M., Beccia, D., and Nevola, R. (2020). Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0243700"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.gastrohep.2020.06.006","article-title":"COVID-19 and liver disease: An update [Actualizaci\u00f3n en COVID-19 y enfermedad hep\u00e1tica]","volume":"43","year":"2020","journal-title":"Gastroenterol. Hepatol. (Engl. Ed.)"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jhep.2020.05.013","article-title":"High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry","volume":"73","author":"Moon","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2020-322118","article-title":"Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: Multi-centre matched cohort","volume":"70","author":"Bajaj","year":"2021","journal-title":"Gut"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s12072-020-10072-8","article-title":"APASL COVID Task Force, APASL COVID Liver Injury Spectrum Study (APCOLIS Study-NCT 04345640). Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)","volume":"14","author":"Sarin","year":"2020","journal-title":"Hepatol. Int."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1111\/liv.14583","article-title":"Impact of chronic liver disease on outcomes of hospitalized patients with COVID-19: A multi-centre United States experience","volume":"40","author":"Hashemi","year":"2020","journal-title":"Liver Int."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2020.06.001","article-title":"High rates of 30-day mortality in patients with cirrhosis and COVID-19","volume":"73","author":"Iavarone","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_138","first-page":"9","article-title":"Non-alcoholic fatty liver disease and metabolic syndrome","volume":"13","author":"Paschos","year":"2009","journal-title":"Hippokratia"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jhep.2020.03.044","article-title":"Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study","volume":"73","author":"Ji","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/jgh.15112","article-title":"Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients","volume":"36","author":"Gao","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/gutjnl-2020-321611","article-title":"Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.dsx.2020.04.033","article-title":"SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects","volume":"14","author":"Michalakis","year":"2020","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1038\/s41366-020-0597-4","article-title":"COVID-19 and the role of chronic inflammation in patients with obesity","volume":"44","author":"Chiappetta","year":"2020","journal-title":"Int. J. Obes. (Lond.)"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.numecd.2020.05.014","article-title":"Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies","volume":"30","author":"Mantovani","year":"2020","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.gastrohep.2020.06.003","article-title":"Liver transplant immunosuppression during the COVID-19 pandemic [Inmunosupresi\u00f3n en el trasplante hep\u00e1tico en la era covid-19]","volume":"43","author":"Forns","year":"2020","journal-title":"Gastroenterol. Hepatol. (Engl. Ed.)"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/hep.31257","article-title":"Perioperative presentation of COVID-19 disease in a liver transplant recipient","volume":"72","author":"Qin","year":"2020","journal-title":"Hepatology"},{"key":"ref_147","first-page":"1489","article-title":"COVID-19 in liver transplant recipients: An initial experience from the U.S.","volume":"146","author":"Lee","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/ajt.15941","article-title":"COVID-19 in solid organ transplant recipients: Initial report from the US epicenter","volume":"20","author":"Pereira","year":"2020","journal-title":"Am. J. Transplant."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S2468-1253(20)30116-3","article-title":"COVID-19 in long-term liver transplant patients: Preliminary experience from an Italian transplant centre in Lombardy","volume":"5","author":"Bhoori","year":"2020","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"e13418","DOI":"10.1111\/tid.13418","article-title":"Liver transplant recipients infected with SARS-CoV-2 in the early postoperative period: Lessons from a single center in the epicenter of the pandemic","volume":"1","author":"Waisberg","year":"2021","journal-title":"Transpl. Infect. Dis."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jhep.2020.07.040","article-title":"Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients","volume":"74","author":"Colmenero","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"219","DOI":"10.15403\/jgld-2513","article-title":"Abnormal liver function tests of patients with coronavirus disease 2019 in Mainland China: A systematic review and meta\u2014Analysis","volume":"29","author":"Xin","year":"2020","journal-title":"J. Gastrointest. Liver Dis."},{"key":"ref_153","first-page":"73","article-title":"Prevalence of abnormal liver function tests in COVID-19 patients at a tertiary care centre","volume":"68","author":"Kaushik","year":"2020","journal-title":"J. Assoc. Physicians India"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s12072-020-10071-9","article-title":"Coronavirus disease (COVID-19) and the liver: A comprehensive systematic review and meta-analysis","volume":"14","author":"Kumar","year":"2020","journal-title":"Hepatol. Int."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s12072-020-10074-6","article-title":"Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: A systematic review and meta-analysis","volume":"14","author":"Wu","year":"2020","journal-title":"Hepatol. Int."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.gastro.2020.05.001","article-title":"AGA Institute rapid review of the GI and liver manifestations of COVID-19, meta-analysis of international data, and recommendations for the consultative management of patients with COVID-19","volume":"159","author":"Sultan","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1053\/j.gastro.2020.04.008","article-title":"High prevalence of concurrent gastrointestinal manifestations in patients with SARS-CoV-2: Early experience from California","volume":"159","author":"Cholankeril","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1053\/j.gastro.2020.05.010","article-title":"Gastrointestinal and hepatic manifestations of 2019 novel coronavirus disease in a large cohort of infected patients from New York: Clinical implications","volume":"159","author":"Hajifathalian","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1053\/j.gastro.2020.04.064","article-title":"Clinical characteristics and outcomes of COVID-19 among patients with pre-existing liver disease in the United States: A multi-center research network study","volume":"159","author":"Singh","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1177\/2050640620931657","article-title":"Patterns of liver injury in COVID-19\u2014A German case series","volume":"8","author":"Schattenberg","year":"2020","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/apt.15962","article-title":"The association between markers of liver injury and clinical outcomes in patients with COVID-19 in Wuhan","volume":"52","author":"Huang","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"572115","DOI":"10.3389\/fmed.2020.572115","article-title":"Pre-existing liver diseases and on-admission liver-related laboratory ests in COVID-19: A prognostic accuracy meta-analysis with systematic review","volume":"7","author":"Vancsa","year":"2020","journal-title":"Front. Med."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.aohep.2020.08.068","article-title":"The effect of liver test abnormalities on the prognosis of COVID-19","volume":"19","author":"Medetalibeyoglu","year":"2020","journal-title":"Ann. Hepatol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.medcli.2020.05.012","article-title":"Evaluation of organ function in patients with severe COVID-19 infections","volume":"155","author":"Zhu","year":"2020","journal-title":"Med. Clin. (Barc.)"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4103\/sjg.SJG_239_20","article-title":"Abnormal liver-related biomarkers in COVID-19 patients and the role of pre-albumin","volume":"26","author":"Li","year":"2020","journal-title":"Saudi J. Gastroenterol."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Bernal-Monterde, V., Casas-Deza, D., Letona-Gim\u00e9nez, L., de la Llama-Celis, N., Calmarza, P., Sierra-Gabarda, O., Betor\u00e9-Glaria, E., Mart\u00ednez-de Lagos, M., Mart\u00ednez-Barredo, L., and Espinosa-P\u00e9rez, M.M. (2020). SARS-CoV-2 infection induces a dual response in liver function tests: Association with mortality during hospitalization. Biomedicines, 8.","DOI":"10.3390\/biomedicines8090328"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/apt.15996","article-title":"Liver involvement is not associated with mortality: Results from a large cohort of SARS-CoV-2-positive patients","volume":"52","author":"Ponziani","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/hep.31301","article-title":"Longitudinal association between markers of liver injury and mortality in COVID-19 in China","volume":"72","author":"Lei","year":"2020","journal-title":"Hepatology"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jhep.2020.12.012","article-title":"Association of liver abnormalities with in-hospital mortality in patients with COVID-19","volume":"74","author":"Ding","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_170","first-page":"7","article-title":"Clinical characteristics of 78 cases of patients infected with coronavirus disease 2019 in Wuhan, China","volume":"21","author":"Lin","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"e639","DOI":"10.1016\/S2214-109X(20)30114-5","article-title":"Use of antiviral drugs to reduce COVID-19 transmission","volume":"8","author":"Clotet","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2147\/CIA.S303629","article-title":"Dynamic changes in liver function tests and their correlation with illness severity and mortality in patients with COVID-19: A retrospective cohort study","volume":"16","author":"Xu","year":"2021","journal-title":"Clin. Interv. Aging"},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Lan, N.T., Thu, N.T., Barrail-Tran, A., Duc, N.H., Lan, N.N., Laureillard, D., Lien, T.T., Borand, L., Quillet, C., and Connolly, C. (2014). Randomized pharmacokinetic trial of rifabutin with lopinavir\/ritonavir-antiretroviral therapy in patients with HIV-associated tuberculosis in Vietnam. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0084866"}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/9\/3\/50\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:24:37Z","timestamp":1760163877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/9\/3\/50"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":173,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["diseases9030050"],"URL":"https:\/\/doi.org\/10.3390\/diseases9030050","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints202105.0552.v1","asserted-by":"object"}]},"ISSN":["2079-9721"],"issn-type":[{"value":"2079-9721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]}}}